Talphera (TLPH) EBT Margin Growth (1y) (2012 - 2023)
Talphera (TLPH) EBT Margin Growth (1y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Talphera | 90.63 Mn | 90.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 205,130.00 |
| Mar 31, 2022 | -21,129.00 |
| Dec 31, 2021 | -39.46 Mn |
| Sep 30, 2021 | 16,013.00 |
| Jun 30, 2021 | -199,679.00 |
| Mar 31, 2021 | 243,837.00 |
| Dec 31, 2020 | 182,802.00 |
| Sep 30, 2020 | 144,114.00 |
| Jun 30, 2020 | 109,292.00 |
| Mar 31, 2020 | 263,294.00 |
| Dec 31, 2019 | -98,781.00 |
| Sep 30, 2019 | 121,059.00 |
| Jun 30, 2019 | -3,032.00 |
| Mar 31, 2019 | -441,838.00 |
| Dec 31, 2018 | -61,780.00 |
| Sep 30, 2018 | -242,939.00 |
| Jun 30, 2018 | -79,734.00 |
| Mar 31, 2018 | -205,841.00 |
| Dec 31, 2017 | -128,035.00 |
| Sep 30, 2017 | -53,531.00 |